M05.05
Felty's syndrome, hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Felty's syndrome is a rare complication of rheumatoid arthritis characterized by the combination of an enlarged spleen (splenomegaly), low white blood cell counts (neutropenia), and inflammation of the joints. When Felty's syndrome affects the hip, it can lead to additional complications related to joint health and mobility. Although it is more commonly associated with the small joints of the hands and feet, involvement of larger joints like the hips can occur, leading to pain and functional limitations.
Causes & Symptoms
Clinical Causes: Chronic rheumatoid arthritis, which causes persistent inflammation in joints Immune system abnormalities that lead to excessive destruction of white blood cells and spleen enlargement Genetic predisposition influencing immune response Environmental factors, such as smoking or infections, that may trigger or exacerbate autoimmune responses
Key Symptoms: Joint pain or stiffness, especially in the hips Swelling and tenderness in the affected joint areas Reduced range of motion in the hips, affecting mobility Signs of infection, such as fever or chills, due to neutropenia Fatigue and general malaise Enlarged spleen detected on physical exam or imaging studies Low levels of white blood cells, increasing the risk of infections
Diagnostic & Treatment
Diagnosis Path: Diagnosing Felty's syndrome involving the hip involves multiple steps: - Medical history review focused on rheumatoid arthritis symptoms and duration - Physical examination to assess joint swelling, tenderness, and spleen size - Blood tests to measure white blood cell counts, presence of rheumatoid factor, and other markers of inflammation - Imaging studies, including X-rays or MRI of the hips, to evaluate joint damage - Bone marrow biopsy in certain cases to rule out other causes of blood cell deficiencies - Additional tests may include ultrasound or CT scans to assess spleen size and detect any related abnormalities
Treatment Protocols: Managing Felty's syndrome with hip involvement aims to control inflammation, reduce symptoms, and prevent joint damage: - Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate or leflunomide, to reduce joint inflammation and slow disease progression - Biologic agents, like tumor necrosis factor (TNF) inhibitors, in severe cases to control immune response - Corticosteroids to quickly decrease inflammation during flare-ups - Antibiotics for infections resulting from neutropenia - Regular monitoring of blood counts and spleen size - Physical therapy to maintain joint function and reduce stiffness - In some cases, surgical intervention, such as hip replacement, may be necessary if joint damage is severe It is important to work closely with a healthcare team to tailor treatment plans specifically to individual needs and disease severity.
Clinical Advice & FAQs
Billing Guidance
Is M05.05 a billable ICD-10 code?
Yes, M05.05 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M05.05?
Clinical documentation must specify the nature of Felty's syndrome, hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference